PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2012; 7(3): e33540.
Published online Mar 23, 2012. doi:  10.1371/journal.pone.0033540
PMCID: PMC3311642
Disrupted Small-World Brain Networks in Moderate Alzheimer's Disease: A Resting-State fMRI Study
Xiaohu Zhao,#1 Yong Liu,#2 Xiangbin Wang,1 Bing Liu,2 Qian Xi,1 Qihao Guo,3 Hong Jiang,1 Tianzi Jiang,2,4,5* and Peijun Wang1*
1Imaging Department, TongJi University, TongJi Hospital Shanghai, China
2LIAMA Center for Computational Medicine, National Laboratory of Pattern Recognition, Institute of Automation, the Chinese Academy of Sciences, Beijing, China
3State Key Laboratory of Medical Neurobiology, Department of Neurology, Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
4Key Laboratory for NeuroInformation of Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
5The Queensland Brain Institute, The University of Queensland, Brisbane, Australia
Olaf Sporns, Editor
Indiana University, United States of America
#Contributed equally.
* E-mail: jiangtz/at/nlpr.ia.ac.cn (TJ); tongjipjwang/at/vip.sina.com (PW)
Conceived and designed the experiments: XHZ YL PJW TZJ. Performed the experiments: QX HJ. Analyzed the data: XBW YL BL. Contributed reagents/materials/analysis tools: QHG. Wrote the paper: XHZ YL.
Received November 30, 2011; Accepted February 10, 2012.
The small-world organization has been hypothesized to reflect a balance between local processing and global integration in the human brain. Previous multimodal imaging studies have consistently demonstrated that the topological architecture of the brain network is disrupted in Alzheimer's disease (AD). However, these studies have reported inconsistent results regarding the topological properties of brain alterations in AD. One potential explanation for these inconsistent results lies with the diverse homogeneity and distinct progressive stages of the AD involved in these studies, which are thought to be critical factors that might affect the results. We investigated the topological properties of brain functional networks derived from resting functional magnetic resonance imaging (fMRI) of carefully selected moderate AD patients and normal controls (NCs). Our results showed that the topological properties were found to be disrupted in AD patients, which showing increased local efficiency but decreased global efficiency. We found that the altered brain regions are mainly located in the default mode network, the temporal lobe and certain subcortical regions that are closely associated with the neuropathological changes in AD. Of note, our exploratory study revealed that the ApoE genotype modulates brain network properties, especially in AD patients.
Alzheimer's disease (AD) is the leading cause of intellectual impairment in the elderly worldwide [1], [2], [3]. In its early stages, the most commonly recognized symptom is an inability to acquire new memories, such as difficulty in recalling recently observed facts, which is commonly referred to as the loss of episodic memory. As the disease progresses, extensive cognitive impairments begin to manifest, including language breakdown and long-term memory loss. Eventually, most brain functions deteriorate, ultimately leading to death. The neural basis underlying the functional damage is not yet fully understood. Recent studies based on multimodal imaging have provided evidence supporting the notion of AD as a disconnection syndrome [4], [5], [6].
Information interactions between interconnected brain regions are believed to be a basis of human cognitive processes [7], [8]. Networks have been used to model the brain and provide a new tool for understanding functional integration and segregation in the human brain and also the pathogenesis and treatment of neurological disorders [8], [9], [10], [11]. Elucidation of the complexity of brain networks will offer fundamental new insights into the general organizational principles of neurological functions from both global and integrative perspectives [8], [12], [13], [14]. Characterizing the underlying architecture of brain networks is an important issue in neuroscience.
Previous brain network studies of AD patients have revealed that their cognitive functional deficits may be due to abnormalities in the connectivity between different brain areas, although there is no consensus as to what the alteration pattern is [15], [16], [17], [18], [19], [20], [21]. In 2007, using EEG data, Stam and colleagues found that although the network clustering coefficient was unchanged in AD patients, the patients displayed a longer characteristic path length [19]. However, in 2008, using fMRI data, Supekar and colleagues found that AD patients had a lower clustering coefficient and no change in characteristic path length [20]. In a structural imaging study the same year, He and colleagues found a higher clustering coefficient and longer characteristic path length in the brain structural networks of AD patients [17]. In 2009, using MEG data, Stam and colleagues found a lower clustering coefficient and higher characteristic path length in the brain network in AD patients [21]. Furthermore, in 2010, using resting-state fMRI data, Sanz-Arigita and colleagues found the clustering coefficient to be unchanged but a lower average shortest path in AD patients [18]. In the same year, using structural MRI data, Yao and colleagues found a higher clustering coefficient and longer average shortest path length in AD patients; the authors also found that network topological measures in mild cognitive impairment (MCI) patients were between those of AD and NC groups [15]. It should be noted that until now, studies of the altered brain network pattern in AD patients have not produced consistent results. With these studies, researchers do not obtain consistent results which may arise from the differences in the groups of subjects, different measurements and the image modalities used. As previously established, patients at different stages may manifest different behavioral symptoms with distinct underlying neural mechanisms [22], [23], [24]. Thus, a study focused on a group of subjects with a specific disease stage (for example, mild, moderate or severe AD) will help us understand the network alteration in AD. In addition, the apolipoprotein E (ApoE) gene, located on chromosome 19, is a major susceptibility gene and is most clearly linked to late-onset AD. ApoE4 is the risk allele of the ApoE gene in AD [25]. An increasing amount of evidence has indicated that ApoE4 modulates the brain activity of both normal aging and AD patients as measured by fMRI [26], [27], [28], [29]. However, to our knowledge, the question of whether the ApoE gene affects the topological properties of AD in the brain has not yet been studied.
In the current study, we specifically focused on moderate AD patients to directly investigate the hypothesis that the brain network of AD is characterized by the disruption of efficient small-world topological properties based on resting-state fMRI data. First, binary brain networks of individual brains were constructed with 90 brain regions as nodes extracted by an automated anatomical labeling (AAL) template [30] with inter-regional functional connectivity as edges. Second, the topological parameters of the brain network (clustering coefficient, shortest path length, global efficiency and local efficiency) were evaluated at different connection densities. Third, statistical differences between the AD and NC groups were evaluated at both global and nodal levels. Finally, to evaluate the effects of genotype on global network properties, we compared network properties between NCs without ApoE4 and ApoE4− and ApoE4+ AD patients.
Subjects
Only moderate AD patients and the age and education matched NC were included in the present study. All subjects gave voluntary and informed consents according to the standards set by the Ethics Committee of Tongji Hospital. The cognitive and neuropsychology tests were administered to each participant individually by a professional appraiser in the neuropsychological research center.
The cognitive abilities of the AD patients and controls were determined by Mini-Mental State Examination (MMSE) and Mattis Dementia Rating Scale(DRS) equivalent to that of the age-matched cognition level. The AD patients met the criteria for dementia as described by the National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer Disease and Related Disorders Association (NINCDS-ADRDA) [31].The subjects were assessed clinically with the Clinical Dementia Rating (CDR) scale [32] and categorized as non-demented normal controls (NCs) (CDR = 0) and those with moderate stages of AD (CDR = 2). The inclusion criteria for both the normal controls and AD patients were as follows: 1) no anxiety or depressive disorders within a month; 2) normal vision and hearing; 3) cooperation with the cognitive tests; 4) age 50–85 years old with no constraints on education level; 5) no diagnosed stroke history; 6) no more than one lacunar infarction and no patchy or diffuse leukoaraiosis as determined by MRI examination.
The exclusion criteria included: 1) age under 50 years old or above 85 years old; 2) the presence of the following diseases or disease histories within a year: local brain injury, traumatic brain injury with loss of consciousness, confusion immediately following traumatic brain injury, serious mental diseases and alcohol or drug abuse; 3) obviously incomplete heart, liver, kidney or lung function; blood disorders; endocrine diseases; neurosyphilis; 4) clinical depression; 5) cancer; 6) excessive psychotropic drug use.
All subjects underwent a complete physical and neurological examination using an extensive battery of neuropsychological assessments and standard laboratory tests. Brain MRI scans of the AD patients showed no abnormalities other than brain atrophy.
ApoE genotype
Venous blood samples from all subjects were added to EDTA anticoagulant after fMRI data acquisition. The technicians were blind to the diagnosis of the participants. ApoE genotypes were determined using standard methods [33].
The clinical and demographic data for the age- and gender-matched participants, excluding data from subjects with excessive head motion (see data preprocessing section), are shown in Table 1.
Table 1
Table 1
Demographic, clinical and neuropsychological data.
Data acquisition
Images were scanned on an American Marconi 1.5T EDGE ECLIPSE superconducting MRI system in the department of radiology of Tongji Hospital of Tongji University, Shanghai. Resting-state BOLD-fMRI was collected axially using an echo-planar imaging (EPI) sequence with the following parameters: repetition time (TR) = 2000 ms, echo time (TE) = 40 ms, flip angle (FA) = 90°, field of view (FOV) = 24 cm×24 cm, matrix = 64×64, NEX = 1, slices = 21, thickness = 6 mm, gap = 1 mm. The scan lasted for 320 seconds. The subjects were instructed to keep their eyes closed, relax their minds and remain as motionless as possible during the data acquisition. Rubber earplugs were used to reduce noise, and foam cushioning was used to fix the head to reduce motion artifacts.
Data preprocessing
Unless specifically stated otherwise, all the preprocessing was carried out using statistical parametric mapping (SPM8, http://www.fil.ion.ucl.ac.uk/spm). The first 5 images were discarded in consideration of magnetization equilibrium. The remaining 155 images were corrected for the acquisition time delay among different slices, and then the images were realigned to the first volume for head-motion correction. The fMRI images were further spatially normalized to the Montreal Neurological Institute (MNI) EPI template and resampled to a 2-mm cubic voxel. Several sources of spurious variance including the estimated motion parameters, the linear drift, and the average time series in the cerebrospinal fluid and white matter regions were removed from the data through linear regression. Finally, temporal band-pass filtering (0.01≤f≤0.08 HZ) was performed to reduce the effects of low-frequency drift and high-frequency noise [34], [35].
The time course of head motion was obtained by estimating the translations in each direction and the rotations in angular motion about each axis for each of the 155 consecutive volumes. All the subjects included in this study exhibited a maximum displacement of less than 3 mm (smaller than the size of a voxel in plane) at each axis and an angular motion of less than 3° for each axis. Data from two subjects were excluded due to excessive motion. Furthermore, for exclusion the influence of head motion on functional connectivity results, an extra evaluation of the movement parameter between AD and NC group have been performed in line with the procedures described in Van Dijk et al. [36]
Anatomical parcellation
The registered fMRI data were segmented into 90 regions (45 for each hemisphere, Table S1) using an automated anatomical labeling template [30], which has been used in several previous studies [20], [35], [37], [38], [39], [40]. For each subject, a representative time series of each individual region was then obtained by simply averaging the fMRI time series over all voxels in this region.
Graph theoretical analysis
Brain network construction
The Pearson correlation coefficients of each area were calculated for each pair of 90 functionally connected regions. To simplify the statistical calculation, a Fisher r-to-z transformation was performed to increase the normality of the correlation matrix. Then, the absolute z values were converted into a binary connection matrix to make a graphic model of a brain network. That is, if the absolute z(i,j) (Fisher r-to-z of the partial correlation coefficient) of a pair of brain regions, i and j, exceeds a given threshold T, an edge is said to exist; otherwise it does not exist. Sparse networks of each subject were constructed using a minimum spanning tree method followed by global thresholds [41].
The degree of each node, Di, is defined as the number of nodes directly connected to the region i. The total number of edges in a graph, divided by the maximum possible number of edges, N(N-1)/2, that is, An external file that holds a picture, illustration, etc.
Object name is pone.0033540.e001.jpg, is called the connection density or cost of the network, which measures how expensive it is to build the network [42]. The graphs were constructed over the whole range of connection densities or costs, from 4% to 40%, at 2% intervals. Global and nodal network properties were evaluated statistically over the range of 4–40%, and nodal properties were also analyzed at a connection density of 22%, at which the global efficiency showed the largest differences between AD and NC subjects.
Topological properties of the brain functional networks
All other topological properties considered were calculated using in-house software (Brat, www.ccm.org.cn/brat). These include the clustering coefficients (Cp), shortest path length (Lp), small-worldness, global efficiency (Eglobal) and local efficiency (Elocal), each of which have been described previously and used in several prior studies [35], [38], [39]. Table 2 provides an overview of the parameters and their meaning in brain functional networks. A detailed description of these parameters can be found in the supplemental material (Text S1).
Table 2
Table 2
Overview of the measurements and their meaning in brain functional network.
Statistical analysis
Statistical comparisons of topological measures between the two groups were performed using a two-sample two-tailed t-test for each value over a wide range of connection densities (P<0.05). We determined the regional distribution of any statistically significant changes in the topological properties found between the two groups.
Exploratory study of gene effect
To investigate the potential effect of ApoE genotype on network topological properties, we evaluated the differences between the NC ApoE4− group and the AD ApoE4− and ApoE4+ groups and those between the AD ApoE4− and ApoE4+ groups using a two-sample two-tailed t-test for each value over a wide range of connection densities (P<0.05). We determined the regional distribution of any statistically significant changes in the topological properties found between the two groups.
Caret v5.61 software was used to make cortical surface representations of the regional distributions of fixed group level network property alterations in the AD groups [43], [44]. The value plotted at a given point is the value of the template volume at a point below the surface at the level of the cortical layer.
Cognitive and neuropsychology test
There were no significant differences in gender (P = 0.591) or age (P = 0.182) between the NC and AD groups. The MMSE scores of the NC group averaged 27.8±1.3, which fits the normal age-matched standard. The MMSE scores of the AD group averaged 15.3±2.9, which is significantly different from that of the NC group (P<0.001). The Mattis Dementia Rating Scale (DRS) scores of the NC group averaged 132.32±5.0 and those of the AD group averaged 96.00±10.8, and the scores also markedly differed from each other (P<0.001) (Table 1). There was one ApoE4+ NC subject, 19 ApoE4− NC subjects, 19 AD ApoE4− subjects and 14 AD ApoE4+ subjects. There were no significant differences in either gender or age between the NC ApoE4−, AD ApoE4− and AD ApoE4+ groups (Table 1). In addition, there were no significant differences in MMSE or DRS scores between the ApoE4− and ApoE4+ AD groups (Table 1).
Evaluation of the movement parameter between AD and NC groups
The displacements of the MAD and NC groups are 0.89±0.39 mm and 0.80±0.60 degree, respectively, and the rotations of the MAD and NC groups are 0.69±0.33 mm and 0.52±0.30 degree, respectively. No significant differences were found between the experimental groups (two-sample, two-tailed t-test; P = 0.51 for displacement and P = 0.07 for rotation).
Direct comparisons between the AD and NC groups
The mean functional connectivity matrix of each group was calculated by averaging the N×N (N = 90 in the present study) absolute connection matrix of all the subjects within the group. In the normal group, most of the strong functional connectivities (large z-scores) were between inter-hemispheric homogeneous regions, within a lobe, and between anatomically adjacent brain areas (Fig. S1). This functional connectivity pattern is consistent with many previous studies of whole brain functional connectivity in the resting-state [35], [38], [39], [45]. The AD group showed a similar functional connectivity pattern to that of the healthy group; however, the correlation strength was significantly altered (F1, 51 = 22.2, P<0.001).
Altered topological properties of functional networks in AD subjects
In the range of 0.04≤Cost≤0.4, clustering coefficients (Cp), shortest path length (Lp), small-worldness, global efficiency (Eglobal) and local efficiency (Elocal) values for the AD and NC groups were calculated and then compared using a two sample two-tailed t-test. With increasing connection density, Cp, Eglobal and Elocal all increased, whereas Lp decreased in both the AD and NC groups (Fig. 1). Across the entire threshold range, Cp and Elocal values were notably higher in the AD group than in the NC group (P<0.05) (Fig. 1 A and D). In a wide threshold range (0.04~0.34), the Lp of the AD group was also significantly greater than in the normal controls (P<0.05) (Fig. 1 B), but the Eglobal of the AD group was significantly lower than that of the NC group in this range (P<0.05) (Fig. 1C).
Figure 1
Figure 1
Change of network parameters as a function of connection density (Cost).
The γ, λ and σ (a detailed definition can be found in Table 2 and the supplemental material) values of the brain network as a function of connection density within both groups is shown in Fig. 2. Both groups fit γ = Cpreal/Cprand>1 and λ = Lpreal/Lprand≈1 (Fig. 2 A and B). Thus, the functional networks of AD patients and NCs fit the definition of small-worldness [46]. The γ and λ values were significantly higher in the AD group over nearly the entire range of connection density (Fig. 2 A and B). The σ values of the AD group were significantly larger than that of the NC group in the range of 0.14≤Cost≤0.4(Fig. 2 C).
Figure 2
Figure 2
Change of small-world network definition parameters as a function of connection density (Cost).γ
Distribution of brain regions with altered network properties in AD subjects
Two-sample two-tailed t-tests for each of the 90 regions was performed to further localize the nodes that demonstrated significant differences between the AD and normal control groups.
Fig. 3 shows the frequencies of the altered nodes that were found across the 19 threshold times (P<0.05) in the AD patients (Fig. S2). As shown in Fig. 3, the regions showing significant alterations in Cp and Elocal are widely distributed across the brain, especially in the default mode network, which is composed of the right posterior cingulate gyrus (PCC_R), the anterior cingulate and paracingulate gyrus (ACC), the opercular part of the inferior frontal gyrus (IFGoper), the superior frontal gyrus (SFG), regions in the temporal lobe such as the superior temporal gyrus (STG), and regions in the subcortical structure such as the right thalamus (THA_R), left lenticular nucleus pallidum (PAL_L) and right lenticular nucleus putamen (PUT_R). The regions showing significant alterations in Eglobal and Lp are distributed primarily in regions of the temporal lobe, such as the middle temporal gyrus temporal pole (MTGp) and right middle temporal gyrus (MTG_R), and sensory motor regions, such as the right supplementary motor area (SMA_R) and right precentral gyrus (PreCG_R).
Figure 3
Figure 3
Surface rendering of the distribution of altered nodes (P<0.05).
We further explored the brain regions where the topological parameters were significantly different between AD patients and NCs at the cost of 0.22 (global efficiency showed the most prominent differences at this connection density). As shown in Fig. 4 (A/B/D), most of network topological properties (Cp, Lp and Elocal) were found to be increased in AD patients relative to controls across widely distributed regions (also see Fig. S3). We generally grouped the altered regions into three clusters. The first cluster is the default mode network (Fig. 4); nearly all the regions belonging to a typical default mode network can be identified in our results, such as the ACC, PCC, middle prefrontal cortex (MPFC), hippocampus (HIP) and inferior parietal cortex (IPL). The second cluster includes parts of the subcortical structure such as the thalamus (THA), lenticular nucleus putamen (PUT) and INS (Fig. 4). The third cluster consists of regions of the temporal lobe such as the superior/middle temporal gyrus temporal pole (STGp/MTGp) and the bilateral middle temporal gyrus (MTG), which showed significantly decreased Eglobal in AD patients (Fig. 4C). Eglobal was also found to be decreased in AD patients in motor areas such as SMA_R and PreCG_R.
Figure 4
Figure 4
Surface rendering of the distribution of altered nodes at a connection density of 22%.
The ApoE4 gene modulates global network properties
Compared with the NC ApoE4− subjects, the AD patients had significantly higher Cp, higher Elocal, and longer Lp, but lower Eglobal (Fig. 1, E–H) regardless of their ApoE4 status (P<0.05). Relative to the AD ApoE4− group, the AD ApoE4+ group showed lower Cp, lower Elocal, shorter Lp, and higher Eglobal. Although these differences did not reach statistical significance, the trend was clear (Fig. 1, E, F, G, H, Fig. 2, D, E, F). In addition, the brain regions where the topological parameters significantly differ between the patients carrying and not carrying ApoE4 gene were investigated. The AD ApoE4− patients displayed higher Cp, higher Elocal, and longer Lp in the temporal cortex, frontal cortex and medial prefrontal cortex, and they displayed lower Eglobal in the frontal cortex (Fig. 5 D, E, F, Fig. S4).
Figure 5
Figure 5
Surface rendering of the distribution of nodes differing between the AD ApoE4+ and ApoE4− groups.
Our results revealed that the topological properties of the brain networks in the moderate AD group were disrupted compared to those in the normal controls. Specifically, the altered regions were mainly distributed in the default mode network, the temporal lobe and subcortical structures. More importantly, we also evaluated the effects of genotype on network properties, especially in the AD group.
Small-world topology in normal individuals
The human brain is a functionally specialized organ with anatomically distinct structures. Cognition requires a high level of functional interaction between brain regions to support daily activities. Recent studies with noninvasive brain imaging technologies such as MRI, EEG, and MEG have demonstrated that the human brain's structural and functional networks have small-world properties [9], [10], [47]. The brain networks in NCs and AD patients fit the features of small-world networks, suggesting that the human brain supports rapid real-time integration of information across segregated sensory brain regions [12], [13] to confer resilience against pathological attacks [39] and to maximize efficiency at a minimal cost for effective information processing between different brain regions [38], irrespective of age or illness status.
Altered small-world topology in AD patients
Our investigation revealed that network topological properties are altered in AD patients, consistent with previous studies [15], [17], [18], [19], [20], [21], [48].
Cp is a measure of local network connectivity. It reflects the local efficiency and error tolerance [49] of a network. Higher network clustering coefficients indicate more concentrated clustering of local connections and stronger local information processing capacity [10]. The Cp of brain functional networks was found to be higher in AD patients, indicating that these patients have stronger local information processing capacity. This finding is consistent with previous structural network studies in AD [15], [17].
The average shortest path length (Lp) of a network reflects how the network connects internally [46]. In brain networks, the shortest path ensures the effective integration and fast transmission of information between distant brain areas. Generally speaking, the integration and transmission of information are the bases of cognitive processing [8], [11], [13]. Our results demonstrate that the average shortest path of the brain functional networks in AD patients was significantly greater than that in NCs, indicating that the long distance information integration and transmission capacity of neurons is reduced in AD patients [15], [18], [19]. Together with the lower global efficiency in AD, these results suggest that information transfer between brain regions is more difficult in AD patients. Our results are consistent with several studies reporting attenuated long-distance functional connections and increased local functional connections in AD patients [50], [51], [52].
Altered network properties at the node level in AD subjects
Comparisons of Cp, Lp, Elocal and Eglobal provided us a perspective with which to investigate differences at the global level, and further nodal level comparisons localized the regions with significantly divergent brain network topological properties. We first explored the brain regions in which AD-related alterations were most likely to occur, and we further investigated the brain regions where the topological properties of AD patients differed significantly from those of the NCs. Our results revealed nearly overlapping patterns of brain regions (Fig. 3 and Fig. 4) where higher frequency alterations occurred, thereby showing significant differences between the two groups. We generally grouped these regions into three clusters of the default mode network, the subcortical structure and the temporal lobe. These regions had a higher probability of significantly abnormal topological properties in AD patients compared to NCs.
The default mode network has received growing attention over the last decade in neuroimaging studies [53], [54] investigating the functions of remembering the past, envisioning future events, and considering the thoughts and perspectives of other people [55], [56], [57], [58]. The relationships between the default mode network and AD and MCI have been extensively investigated using multiple imaging approaches including PET, structural MRI and fMRI [3], [53], [59]. In all instances, from metabolism changes to structural atrophy to functional abnormalities, these multiple modality methods have consistently revealed abnormal changes in the default mode network of AD patients. For example, previous studies using PET and single photon emission computed tomography techniques found that AD patients had abnormally low cerebral blood flow and low cerebral metabolic rates for glucose in many brain regions, including the parietal, temporal, and prefrontal cortices and the PCC [60], [61], [62], [63], [64]. Metabolic studies have revealed that the pattern of hypometabolism bears a striking resemblance to the regions comprising the default network [65], [66]. Structural MRI has shown gray matter loss in some regions belonging to the default network [67], [68]. Several fMRI studies [59], [65], [69], [70] have revealed consistent disruption with metabolic and structural changes in the default mode network in AD patients. Thus, our results complement and extend previous topological studies revealing a disrupted default network in AD patients.
Another important cluster in which the network properties are altered is the subcortical structure, particularly the thalamus and putamen. The thalamus is an important region with complex functions. In particular, every sensory system (with the exception of the olfactory system) includes a thalamic nucleus that receives sensory signals and sends them to the associated primary cortical region. The anterior and dorsal medial nuclei of the thalamus [71] and mammillo-thalamic tract [72] were found to be involved in episodic memory, which is specifically impaired in AD [73]. Indeed, a clinical case study and EEG studies have consistently demonstrated the important role of the human thalamus in language, executive functioning, attention and memory functions [74], [75]. Language, executive function, attention and memory functions have been shown to be broadly deteriorated in AD patients. Zarei and colleagues showed regional thalamic degeneration in AD patients by combining shape and structure connectivity analysis [76]. Wang and colleagues found that the functional connectivity pattern between the thalamus and the default mode network was significantly altered in early stages of AD [77]. The putamen has been found to be involved in reinforcement learning and implicit learning [78]. Alterations in the network properties of this subcortical structure are thought to be related to the episodic memory impairment in AD.
The temporal lobe is one of the largest lobes in the human brain with functions ranging from primary auditory sensation to high cognitive roles such as language, social cognition and memory [79]. The medial temporal lobe may be an early and profoundly involved area of neurofibrillary tangles, which is why a considerable amount of studies of the anatomic basis for memory impairment in AD has focused on the hippocampus and other medial temporal lobe structures [80]. Increasing evidence has shown that the superior temporal gyrus is equally important to social cognition, regulation of behavior, and the neural mechanisms of imitation [79]. Numerous studies have reliably revealed significant atrophy of the temporal gyrus in MCI and AD subjects relative to NCs [81]; these structural changes might reflect the pathological alterations in AD and thus may be related to the dysfunction observed in these patients. Of importance, most regions of the temporal lobe are involved in the default mode network, such as the hippocampus, lateral temporal cortex and the pole of the temporal cortex, which are attributed to the dorsal medial temporal lobe subsystem of the default mode [82]. As discussed above, the topological changes in the temporal lobe might be indirectly associated with the broad cognitive functional losses in AD such as the language impairment and (especially) the episodic memory impairment.
ApoE genotype modulates topological properties in AD
It is well known that ApoE4 is a major risk factor for late-onset AD [83]. Previous fMRI studies have shown that the ApoE gene affects brain activity during different task in cognitively normal subjects [84], [85], [86] and in AD subjects [2], [87]. However, until now, it has remained unclear whether the ApoE4 gene affects the topological properties of the brain. Thus, in the current study, we aimed to investigate whether ApoE genotype modulates topological properties in AD patients. Here, we selected subjects who do not carry the ApoE4 allele as NCs because the frequency of ApoE4+ is lower in China [88] and Shanghai [33]. Our results showed that AD ApoE4+ patients had lower Cp, lower Elocal, shorter Lp and higher Eglobal compared to ApoE4− patients. Although these differences did not reach statistical significance, the trend was clear, suggesting that significance could be achieved with a larger sample size. Our results are consistent with several MRI and behavioral studies in which AD ApoE4+ and ApoE4− patients showed different disruption patterns [26], . Thus, the differences in topological parameters between the two AD groups may reflect different neurological functional impairments. However, the underlying mechanism of such differences remains to be further explored.
Methodological issues and further discussion
In the current study, we found that clustering coefficients, the shortest path length, local efficiency, and connection density were all elevated in AD patients, whereas global efficiency was lower. These findings are consistent with previous structural network studies [15], [17]. Our current results showed that the clustering coefficient and average shortest path length were both higher in AD patients than in NCs which might not completely align with two previous fMRI studies [18], [20]. Supekar and colleagues reported a lower clustering coefficient with no significant alteration of the average shortest path in AD patients [20]. In contrast, Sanz-Arigita and colleagues showed an unchanged clustering coefficient but a shorter average shortest path in AD patients [18]. Some confounding factors may contribute to this issue. One possibility is methodological differences in the data analyses (for examples, whether spatial smoothing was performed). The effects of local data smoothing can introduce differences between both groups examined due to the higher degree of cortical atrophy characteristic in AD [18], [20]. Another explanation is that there may be methodological differences in the functional connectivity measurements [Pearson's correlation (frequency 0.01–0.08 Hz) in our study, wavelet correlation (frequency 0.01–0.05 Hz) in Sepekar et al., and synchronization likelihood in Sanz-Arigita et al.]. Another important possible reason is the different subjects involved in these studies, especially with respect to the different progressive stages of AD. From a clinical perspective, the heterogeneity of AD and its distinct progressive stages are critical factors that can affect the results of AD studies. Patients at different stages may manifest different behavioral symptoms with different underlying neural mechanisms [22], [23], [24].
The present work mainly focused on moderate AD. Our first consideration is that the existing literature regarding the brain network analysis of AD patients did not clearly point out the progressive stages of AD patients (for example, early, moderate or severe). As discussed above, different AD stages may have different neural mechanisms. The AD patients at the moderate stage may present the typical brain changes and symptom manifested in AD, but with a slight cognitive impairment relative to the severe AD patients. The slight cognitive impairment allows the patients to cooperate in our fMRI study, such as better understanding and carrying out the experimental instructions. The topological alteration in this group will provide extensive additional evidence for the brain alterations present in AD.
We admit that we used the pure network theory to evaluate the altered network pattern in moderate AD subjects. In the present study, we only used the information of the strength of the functional connectivity to generate the binary network of each subject and then evaluate the network properties using graph theory. Such measurement will induce some information loss, such as the weight of functional connectivities, the distance between the two connected brain regions, etc. Thus, the local brain network information (such as local efficiency) here does not reflect the local brain area connections found in prior studies [41], [89], [90]. As previously established, the connection strength reflects the activity coherence, whereas the connection distance reflects the physical distance between regions. As anticipated from the results of prior studies [91], [92], the strength of functional connectivity between regions generally decreased as a non-linear function of increasing anatomical distance between regions. Further work will be needed to estimate the cortical distance information with greater precision, such as including information about white matter tract length or the physical distance between the functionally connected brain regions.
We did not perform a strict correction for multiple comparisons (such as a false discovery ratio); thus, we should be very careful when explaining our findings. To evaluate the robustness of our results, we have performed permutation tests. For each connection density, we have performed permutation statistical analysis for 10,000 trials. The permutation results were similar to our direct comparisons using the two-sample, two-tailed t-test (Table 3, ,4).4). These additional findings suggest that our results are robust and credible.
Table 3
Table 3
Statistical tests on the topological properties of the networks for all the groups after the permutation test.
Table 4
Table 4
Statistical tests on the small-world properties of the networks for all the groups after the permutation test.
Conclusions
In summary, we have investigated the topological properties of human brain functional networks in moderate AD patients using resting-state fMRI. Brain functional networks have efficient small-world properties that support efficient parallel information transfer at a relatively low cost in normal controls. However, this functional organizational mechanism is disturbed in patients with moderate AD, especially in patients with the ApoE4− genotype. This finding is consistent with the hypothesis of dysfunctional integration in the brains of AD patients.
Figure S1
Mean z-score matrices for normal and AD group. Each figure shows a 90×90 square matrix, where the x and y axes correspond to the regions listed in Table S1, and where each entry indicates the mean strength of the functional connectivity between each pair of brain regions. The diagonal running from the upper left to the lower right is intentionally set to zero. The z-score of the functional connectivity is indicated with a colored bar.
(TIF)
Figure S2
The frequencies distributions of altered brain areas in AD group of the 19 different thresholds. Y axes presents significantly altered brain areas. The traverse axes correspond to the frequency of significant differences happened between the two groups from 0.04–0.40 at 0.02 intervals. Clustering coefficient (blue), local efficiency (green), shortest path length (yellow), and global efficiency(brown).
(TIF)
Figure S3
The altered brain areas between AD group (red) and NC group(blue) at the cost of 22%. A, clustering coefficient; B, shortest path length; C, global efficiency; D, local efficiency.
(TIF)
Figure S4
Brain areas showed significant alteration in network properties between ApoE+(red) and ApoE−(blue) groups in AD at the cost of 22%. A, clustering coefficient; B, shortest path length; C, global efficiency; D, local efficiency.
(TIF)
Table S1
Cortical and subcortical regions defined in Automated Anatomical Labeling template in standard stereotaxic space.
(DOCX)
Footnotes
Competing Interests: Tianzi Jiang is an Academic Editor for PLoS ONE - no additional competing interests exist.
Funding: This work was partially supported by the National High Technology Research and Development Program of China (863 Program, Grant No. 2009AA02Z302), the National Key Basic Research and Development Program (973, Grant 2011CBA00408), the Natural Science Foundation of China (Grant Nos. 60831004, 30970818, 30770615, 30970770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
1. Dickerson BC, Sperling RA. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx. 2005;2:348–360. [PubMed]
2. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:280–292. [PMC free article] [PubMed]
3. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19:497–510. [PMC free article] [PubMed]
4. Delbeuck X, Collette F, Van der Linden M. Is Alzheimer's disease a disconnection syndrome? Evidence from a crossmodal audio-visual illusory experiment. Neuropsychologia. 2007;45:3315–3323. [PubMed]
5. Delbeuck X, Van der Linden M, Collette F. Alzheimer's disease as a disconnection syndrome? Neuropsychol Rev. 2003;13:79–92. [PubMed]
6. Liu Y, Wang K, Yu C, He Y, Zhou Y, et al. Regional homogeneity, functional connectivity and imaging markers of Alzheimer's disease: a review of resting-state fMRI studies. Neuropsychologia. 2008;46:1648–1656. [PubMed]
7. Horwitz B. The elusive concept of brain connectivity. Neuroimage. 2003;19:466–470. [PubMed]
8. Sporns O. 2010. Networks of the brain: The MIT Press.
9. Bullmore ET, Bassett DS. Brain graphs: graphical models of the human brain connectome. Annu Rev Clin Psychol. 2011;7:113–140. [PubMed]
10. Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10:186–198. [PubMed]
11. Sporns O, Chialvo DR, Kaiser M, Hilgetag CC. Organization, development and function of complex brain networks. Trends Cogn Sci. 2004;8:418–425. [PubMed]
12. Sporns O, Zwi JD. The small world of the cerebral cortex. Neuroinformatics. 2004;2:145–162. [PubMed]
13. Sporns O. The human connectome: a complex network. Ann N Y Acad Sci. 2011;1224:109–125. [PubMed]
14. Sporns O. Small-world connectivity, motif composition, and complexity of fractal neuronal connections. Biosystems. 2006;85:55–64. [PubMed]
15. Yao Z, Zhang Y, Lin L, Zhou Y, Xu C, et al. Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease. PLoS Comput Biol. 2010;6:e1001006. [PMC free article] [PubMed]
16. He Y, Chen Z, Gong G, Evans A. Neuronal networks in Alzheimer's disease. Neuroscientist. 2009;15:333–350. [PubMed]
17. He Y, Chen Z, Evans A. Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease. J Neurosci. 2008;28:4756–4766. [PubMed]
18. Sanz-Arigita EJ, Schoonheim MM, Damoiseaux JS, Rombouts SA, Maris E, et al. Loss of ‘small-world’ networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity. PLoS One. 2010;5:e13788. [PMC free article] [PubMed]
19. Stam CJ, Jones BF, Nolte G, Breakspear M, Scheltens P. Small-world networks and functional connectivity in Alzheimer's disease. Cereb Cortex. 2007;17:92–99. [PubMed]
20. Supekar K, Menon V, Rubin D, Musen M, Greicius MD. Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput Biol. 2008;4:e1000100. [PMC free article] [PubMed]
21. Stam CJ, de Haan W, Daffertshofer A, Jones BF, Manshanden I, et al. Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain. 2009;132:213–224. [PubMed]
22. Carlesimo GA, Oscar-Berman M. Memory deficits in Alzheimer's patients: a comprehensive review. Neuropsychol Rev. 1992;3:119–169. [PubMed]
23. Forstl H, Kurz A. Clinical features of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 1999;249:288–290. [PubMed]
24. Schmidt C, Redyk K, Meissner B, Krack L, von Ahsen N, et al. Clinical features of rapidly progressive Alzheimer's disease. Dement Geriatr Cogn Disord. 2010;29:371–378. [PubMed]
25. Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci. 2003;26:81–104. [PubMed]
26. Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010;107:10256–10261. [PubMed]
27. Lind J, Persson J, Ingvar M, Larsson A, Cruts M, et al. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain. 2006;129:1240–1248. [PubMed]
28. Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, et al. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Am J Psychiatry. 2006;163:1603–1610. [PubMed]
29. Machulda MM, Jones DT, Vemuri P, McDade E, Avula R, et al. Effect of APOE epsilon4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol. 2011;68:1131–1136. [PubMed]
30. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273–289. [PubMed]
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944. [PubMed]
32. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–2414. [PubMed]
33. Borenstein AR, Mortimer JA, Ding D, Schellenberg GD, DeCarli C, et al. Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P. Am J Alzheimers Dis Other Demen. 2010;25:233–238. [PMC free article] [PubMed]
34. Zhang Z, Liu Y, Jiang T, Zhou B, An N, et al. Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by Regional Homogeneity. Neuroimage. 2012;59:1429–1440. [PubMed]
35. Liu Y, Liang M, Zhou Y, He Y, Hao Y, et al. Disrupted small-world networks in schizophrenia. Brain. 2008;131:945–961. [PubMed]
36. Van Dijk KR, Sabuncu MR, Buckner RL. The influence of head motion on intrinsic functional connectivity MRI. Neuroimage. 2012;59:431–438. [PubMed]
37. Salvador R, Martinez A, Pomarol-Clotet E, Sarro S, Suckling J, et al. Frequency based mutual information measures between clusters of brain regions in functional magnetic resonance imaging. Neuroimage. 2007;35:83–88. [PubMed]
38. Achard S, Bullmore E. Efficiency and cost of economical brain functional networks. PLoS Comput Biol. 2007;3:e17. [PubMed]
39. Achard S, Salvador R, Whitcher B, Suckling J, Bullmore E. A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J Neurosci. 2006;26:63–72. [PubMed]
40. Liu Y, Yu C, Liang M, Li J, Tian L, et al. Whole brain functional connectivity in the early blind. Brain. 2007;130:2085–2096. [PubMed]
41. Alexander-Bloch AF, Gogtay N, Meunier D, Birn R, Clasen L, et al. Disrupted modularity and local connectivity of brain functional networks in childhood-onset schizophrenia. Front Syst Neurosci. 2010;4:147. [PMC free article] [PubMed]
42. Latora V, Marchiori M. Economic small-world behavior in weighted networks. Eur Phys J B. 2003;32:249–263.
43. Van Essen DC, Drury HA, Dickson J, Harwell J, Hanlon D, et al. An integrated software suite for surface-based analyses of cerebral cortex. J Am Med Inform Assoc. 2001;8:443–459. [PMC free article] [PubMed]
44. Van Essen DC. A Population-Average, Landmark- and Surface-based (PALS) atlas of human cerebral cortex. Neuroimage. 2005;28:635–662. [PubMed]
45. Li Y, Liu Y, Li J, Qin W, Li K, et al. Brain anatomical network and intelligence. PLoS Comput Biol. 2009;5:e1000395. [PMC free article] [PubMed]
46. Watts DJ, Strogatz SH. Collective dynamics of ‘small-world’ networks. Nature. 1998;393:440–442. [PubMed]
47. He Y, Chen ZJ, Evans AC. Small-world anatomical networks in the human brain revealed by cortical thickness from MRI. Cereb Cortex. 2007;17:2407–2419. [PubMed]
48. Lo CY, Wang PN, Chou KH, Wang J, He Y, et al. Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer's disease. J Neurosci. 2010;30:16876–16885. [PubMed]
49. Strogatz SH. Exploring complex networks. Nature. 2001;410:268–276. [PubMed]
50. Grady CL, Furey ML, Pietrini P, Horwitz B, Rapoport SI. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain. 2001;124:739–756. [PubMed]
51. Horwitz B, McIntosh AR, Haxby JV, Furey M, Salerno JA, et al. Network analysis of PET-mapped visual pathways in Alzheimer type dementia. Neuroreport. 1995;6:2287–2292. [PubMed]
52. Wang K, Liang M, Wang L, Tian L, Zhang X, et al. Altered functional connectivity in early Alzheimer's disease: a resting-state fMRI study. Hum Brain Mapp. 2007;28:967–978. [PubMed]
53. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1–38. [PubMed]
54. Broyd SJ, Demanuele C, Debener S, Helps SK, James CJ, et al. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev. 2009;33:279–296. [PubMed]
55. Buckner RL, Carroll DC. Self-projection and the brain. Trends Cogn Sci. 2007;11:49–57. [PubMed]
56. Zhang D, Raichle ME. Disease and the brain's dark energy. Nat Rev Neurol. 2010;6:15–28. [PubMed]
57. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007;8:700–711. [PubMed]
58. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, et al. A default mode of brain function. Proc Natl Acad Sci U S A. 2001;98:676–682. [PubMed]
59. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci. 2009;29:1860–1873. [PMC free article] [PubMed]
60. Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, et al. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data. J Cereb Blood Flow Metab. 1993;13:438–447. [PubMed]
61. Bokde AL, Pietrini P, Ibanez V, Furey ML, Alexander GE, et al. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. Arch Neurol. 2001;58:480–486. [PubMed]
62. de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A. 2001;98:10966–10971. [PubMed]
63. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging. 2005;32:486–510. [PubMed]
64. Salmon E, Perani D, Herholz K, Marique P, Kalbe E, et al. Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Hum Brain Mapp. 2006;27:588–597. [PubMed]
65. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709–7717. [PubMed]
66. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am J Psychiatry. 2002;159:738–745. [PubMed]
67. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci. 2003;23:994–1005. [PubMed]
68. Jack CR, Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 2000;55:484–489. [PMC free article] [PubMed]
69. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A. 2004;101:4637–4642. [PubMed]
70. Buckner RL, Snyder AZ, Sanders AL, Raichle ME, Morris JC. Functional brain imaging of young, nondemented, and demented older adults. J Cogn Neurosci. 2000;12(Suppl 2):24–34. [PubMed]
71. Stenset V, Grambaite R, Reinvang I, Hessen E, Cappelen T, et al. Diaschisis after thalamic stroke: a comparison of metabolic and structural changes in a patient with amnesic syndrome. Acta Neurol Scand Suppl. 2007;187:68–71. [PubMed]
72. Yoneoka Y, Takeda N, Inoue A, Ibuchi Y, Kumagai T, et al. Acute Korsakoff syndrome following mammillothalamic tract infarction. AJNR Am J Neuroradiol. 2004;25:964–968. [PubMed]
73. Di Paola M, Macaluso E, Carlesimo GA, Tomaiuolo F, Worsley KJ, et al. Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study. J Neurol. 2007;254:774–781. [PubMed]
74. Johnson MD, Ojemann GA. The role of the human thalamus in language and memory: evidence from electrophysiological studies. Brain Cogn. 2000;42:218–230. [PubMed]
75. Van der Werf YD, Scheltens P, Lindeboom J, Witter MP, Uylings HB, et al. Deficits of memory, executive functioning and attention following infarction in the thalamus; a study of 22 cases with localised lesions. Neuropsychologia. 2003;41:1330–1344. [PubMed]
76. Zarei M, Patenaude B, Damoiseaux J, Morgese C, Smith S, et al. Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease. Neuroimage. 2010;49:1–8. [PubMed]
77. Wang Z, Jia X, Liang P, Qi Z, Yang Y, et al. Changes in thalamus connectivity in mild cognitive impairment: Evidence from resting state fMRI. Eur J Radiol. 2012;81:277–285. [PubMed]
78. Packard MG, Knowlton BJ. Learning and memory functions of the Basal Ganglia. Annu Rev Neurosci. 2002;25:563–593. [PubMed]
79. Adolphs R. Cognitive neuroscience of human social behaviour. Nat Rev Neurosci. 2003;4:165–178. [PubMed]
80. Wolk DA, Dickerson BC. Fractionating verbal episodic memory in Alzheimer's disease. Neuroimage. 2011;54:1530–1539. [PMC free article] [PubMed]
81. Halliday GM, Double KL, Macdonald V, Kril JJ. Identifying severely atrophic cortical subregions in Alzheimer's disease. Neurobiol Aging. 2003;24:797–806. [PubMed]
82. Andrews-Hanna JR, Reidler JS, Sepulcre J, Poulin R, Buckner RL. Functional-anatomic fractionation of the brain's default network. Neuron. 2010;65:550–562. [PMC free article] [PubMed]
83. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923. [PubMed]
84. Adamson MM, Hutchinson JB, Shelton AL, Wagner AD, Taylor JL. Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE varepsilon4 allele. Neuropsychologia. 2011;49:2448–2455. [PMC free article] [PubMed]
85. Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, et al. Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage. 2011;54:602–610. [PubMed]
86. Brainerd CJ, Reyna VF, Petersen RC, Smith GE, Taub ES. Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. Neuropsychology. 2011;25:679–689. [PubMed]
87. Trachtenberg AJ, Filippini N, Ebmeier KP, Smith SM, Karpe F, et al. The effects of APOE on the functional architecture of the resting brain. Neuroimage. 2012;59:565–572. [PubMed]
88. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1–21. [PubMed]
89. Sepulcre J, Liu H, Talukdar T, Martincorena I, Yeo BT, et al. The organization of local and distant functional connectivity in the human brain. PLoS Comput Biol. 2010;6:e1000808. [PMC free article] [PubMed]
90. Tomasi D, Volkow ND. Functional connectivity hubs in the human brain. Neuroimage. 2011;57:908–917. [PMC free article] [PubMed]
91. Salvador R, Suckling J, Coleman MR, Pickard JD, Menon D, et al. Neurophysiological architecture of functional magnetic resonance images of human brain. Cereb Cortex. 2005;15:1332–1342. [PubMed]
92. Salvador R, Suckling J, Schwarzbauer C, Bullmore E. Undirected graphs of frequency-dependent functional connectivity in whole brain networks. Philos Trans R Soc Lond B Biol Sci. 2005;360:937–946. [PMC free article] [PubMed]
Articles from PLoS ONE are provided here courtesy of
Public Library of Science